{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:54:37Z","timestamp":1770508477325,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Publishing Company","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neonatal Network"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:p><jats:bold>I<\/jats:bold>N NEONATOLOGY, EVIDENCE-BASED practice (EBP) relies on well-designed, adequately powered trials to guide practitioners. Several large randomized controlled trials (RCTs) have been conducted to explore the use of fluconazole for fungal prophylaxis in premature infants. Despite the findings of these studies, practice varies among units. In a recent survey of members of the American Academy of Pediatrics (AAP), 34 percent of clinicians indicated that they have used antifungal prophylaxis and only 11 percent of clinicians indicated that a written protocol was in place in their NICU. Intravenous (IV) fluconazole (66 percent), oral nystatin (59 percent), and IV amphotericin (21 percent) were the three most commonly used agents among the respondents.<jats:sup>1<\/jats:sup><\/jats:p>","DOI":"10.1891\/0730-0832.29.5.323","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T14:53:19Z","timestamp":1321455199000},"page":"323-333","source":"Crossref","is-referenced-by-count":5,"title":["Fluconazole to Prevent Systemic Fungal Infections in Infants: Reviewing the Evidence"],"prefix":"10.1891","volume":"29","author":[{"given":"Jamie","family":"Wilkerson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Donze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"793","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-0446","article-title":"Antifungal prophylaxis to prevent neonatal candidiasis: A survey of perinatal physician practices","volume":"118","author":"L. Burwell","year":"2006","journal-title":"Pediatrics"},{"key":"2","first-page":"65","article-title":"Managing clinical knowledge for health care improvement","volume-title":"Yearbook of medical informatics 2000: Patient-centered systems","author":"E. Balas","year":"2000"},{"key":"3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"on behalf of the National Institute of Child Health and Human Development Neonatal Research Network. (2006). Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months","volume":"117","author":"D. Benjamin, Jr.","year":"2006","journal-title":"Pediatrics"},{"key":"4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.inf.0000253973.89097.c0","article-title":"Excess costs of hospital care associated with neonatal candidemia","volume":"26","author":"P. Smith","year":"2007","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QCO.0b013e3282f8adab","article-title":"Fungal prophylaxis in very low birth weight neonates: Nystatin, fluconazole, or nothing?","volume":"21","author":"D. Isaacs","year":"2008","journal-title":"Current Opinion in Infectious Diseases"},{"key":"6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1542\/peds.73.2.144","article-title":"Disseminated fungal infections in very low birth weight infants: Clinical manifestations and epidemiology","volume":"73","author":"J. Baley","year":"1984","journal-title":"Pediatrics"},{"key":"7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00006454-198702000-00009","article-title":"Risk factors associated with candidemia in the neonatal intensive care unit: A case-control study","volume":"6","author":"D. Weese-Maye","year":"1987","journal-title":"Pediatric Infectious Disease"},{"key":"8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1542\/peds.83.1.101","article-title":"Mucocutaneous and invasive candidiasis among very low birth weight (<1500 g) infants in intensive care nurseries: A prospective study","volume":"83","author":"R. Faix","year":"1989","journal-title":"Pediatrics"},{"key":"9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","article-title":"Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group","volume":"19","author":"L. Saiman","year":"2000","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-970078","article-title":"Fungal colonization in the neonatal intensive care unit: Risk factors, drug susceptibility, and association with invasive fungal infections","volume":"24","author":"E. Farmaki","year":"2007","journal-title":"American Journal of Perinatology"},{"key":"11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1515\/JPM.2007.055","article-title":"Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit","volume":"35","author":"P. Manzoni","year":"2007","journal-title":"Journal of Perinatal Medicine"},{"key":"12","volume-title":"Goodman and Gillman's the pharmacologic basis of therapeutics","author":"L. Brunton","year":"2006"},{"key":"13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00006454-199811000-00010","article-title":"Candida fungemia in neonates treated with fluconazole: Report of forty cases, including eight with meningitis","volume":"17","author":"M. Huttova","year":"1998","journal-title":"Pediatric Infectious Diseases Journal"},{"key":"14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000247261","article-title":"Fluconazole-induced toxic epidermal necrolysis in a patient with human immunodeficiency virus infection","volume":"187","author":"A. Azon-Masoliver","year":"1993","journal-title":"Dermatology"},{"key":"15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0140-6736(91)90112-3","article-title":"Stevens-Johnson syndrome after fluconazole","volume":"338","author":"M. Gussenhoven","year":"1991","journal-title":"Lancet"},{"key":"16","unstructured":"Clerihew, L., Austin, N., McGuire, W. (2009). Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. <i>Cochrane Database of Systematic Reviews, 4<\/i>, CD003850."},{"key":"17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajh.10234","article-title":"Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation","volume":"71","author":"L. Koh","year":"2002","journal-title":"American Journal of Hematology"},{"key":"18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2005.03.036","article-title":"Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants <1000 grams birth weight","volume":"147","author":"D. Kaufman","year":"2005","journal-title":"The Journal of Pediatrics"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Klimko, N., Kolbin, A., & Shabalov, N. (2007). Antifungal chemoprophylaxis in the very low birth weight neonates: A prospective randomised controlled study. Abstracts of the 17th European Congress of Clinical Microbiology and Infectious Diseases\/25th ICC. Munich, Germany. March 31\u2013April 3, 2007. Clinical Microbiology and Infection, 13 (Suppl. 1), S258.","DOI":"10.1016\/S0924-8579(07)70815-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Cabrere, C., Frank, M., Carter, D., & Bhatia, J. (2002). Fluconazole prophylaxis against systemic candidiasis after colonization: A randomized double-blinded study. Abstract in Section on Perinatal Pediatrics, 2002 American Academy of Pediatrics- National Conference and Exhibition October 19-20, Boston, MA. <i>Journal of Perinatology, 22<\/i>, 594\u2013622. doi:10.1038\/sj.jp.7210812.","DOI":"10.1038\/sj.jp.7210812"},{"key":"21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1203\/00006450-199804001-01507","article-title":"Fluconazole versus nystatin prophylaxis for fungal infection in very low birth weight (VLBW) infants","volume":"44","author":"K. Violaris","year":"1998","journal-title":"Pediatric Research"},{"key":"22","first-page":"1226","article-title":"Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence","volume":"42","author":"S. Dutta","year":"2005","journal-title":"Indian Pediatrics"},{"key":"23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11096-005-7909-6","article-title":"Fungal chemoprophylaxis with fluconazole in preterm infants","volume":"27","author":"J. Sesmero","year":"2005","journal-title":"Pharmacy World and Science"},{"key":"24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpeds.2005.02.020","article-title":"Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants","volume":"147","author":"G. Bertini","year":"2005","journal-title":"The Journal of Pediatrics"},{"key":"25","doi-asserted-by":"crossref","DOI":"10.1136\/adc.2006.094359","article-title":"Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection","volume":"92","author":"B. McCrossan","year":"2007","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"key":"26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1542\/peds.2005-1969","article-title":"Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants","volume":"117","author":"S. Uko","year":"2006","journal-title":"Pediatrics"},{"key":"27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.jp.7211570","article-title":"Fluconazole prophylaxis in extremely low birth weight infants: Association with cholestasis","volume":"26","author":"Z. Aghai","year":"2006","journal-title":"Journal of Perinatology"},{"key":"28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpeds.2005.04.016","article-title":"Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit","volume":"147","author":"C. Healy","year":"2005","journal-title":"Journal of Pediatrics"},{"key":"29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1542\/peds.2007-1130","article-title":"Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species","volume":"121","author":"C. Healy","year":"2008","journal-title":"Pediatrics"},{"key":"30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.jp.7211914","article-title":"Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure","volume":"28","author":"J. Weitkamp","year":"2008","journal-title":"Journal of Perinatology"},{"key":"31","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole prophylaxis against fungal colonization and infection in preterm infants","volume":"345","author":"D. Kaufman","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1542\/peds.107.2.293","article-title":"Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant","volume":"107","author":"S. Kicklighter","year":"2001","journal-title":"Pediatrics"},{"key":"33","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa065733","article-title":"A multicenter, randomized trial of prophylactic fluconazole in preterm neonates","volume":"356","author":"P. Manzoni","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"34","first-page":"830","article-title":"Prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants","volume":"44","author":"T. Parikh","year":"2007","journal-title":"Indian Pediatrics"},{"key":"35","unstructured":"Public Health Resource Unit. (2006). Critical Appraisal Skills Programme (CASP): 10 questions to help you make sense of reviews. Retrieved January 5, 2008, from <a target=\"_blank\" href='http:\/\/www.phru.nhs.uk\/Docs_Links\/S.Reviews%20Appraisal%20Tool.pdf'>http:\/\/www.phru.nhs.uk\/Docs_Links\/S.Reviews%20Appraisal%20Tool.pdf<\/a>"},{"key":"36","unstructured":"GraphPad QuickCalcs. (2002). Computing the number needed to treat (NNT). GaphPad software Inc. Retrieved December 9, 2009 from <a target=\"_blank\" href='http:\/\/www.graphpad.com\/quickcalcs\/NNT1.cfm'>http:\/\/www.graphpad.com\/quickcalcs\/NNT1.cfm<\/a>"},{"key":"37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2006.11.017","article-title":"Risk of resistance associated with fluconazole prophylaxis: Systematic review","volume":"54","author":"L. Brion","year":"2007","journal-title":"The Journal of Infection"},{"key":"38","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1542\/peds.2008-1837","article-title":"Fluconazole prophylaxis decreases the combined outcome of invasive Candida infections or mortality in preterm infants","volume":"122","author":"D. Kaufman","year":"2008","journal-title":"Pediatrics"},{"key":"39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1542\/peds.2008-0068","article-title":"First, do no harm","volume":"121","author":"D. Benjamin, Jr.","year":"2008","journal-title":"Pediatrics"},{"key":"40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/jp.2008.38","article-title":"Why prevent invasive Candida infections?","volume":"28","author":"D. Kaufman","year":"2008","journal-title":"Journal of Perinatology"},{"key":"41","doi-asserted-by":"crossref","DOI":"10.1136\/adc.2008.145359","article-title":"Prophylactic oral nystatin for preterm babies under 33 weeks' gestation decreases fungal colonisation and invasive fungaemia","volume":"94","author":"K. Ganesan","year":"2009","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"}],"container-title":["Neonatal Network"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/0730-0832.29.5.323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T19:31:04Z","timestamp":1639683064000},"score":1,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/0730-0832.29.5.323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,9,1]]},"published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1891\/0730-0832.29.5.323"],"URL":"https:\/\/doi.org\/10.1891\/0730-0832.29.5.323","relation":{},"ISSN":["0730-0832","1539-2880"],"issn-type":[{"value":"0730-0832","type":"print"},{"value":"1539-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}